Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Objectives: To determine the impact of the coronavirus disease 2019 (COVID-19) pandemic
on healthcare-associated infection (HAI) incidence in US hospitals, national-and state-level …

Rationale: Current guidelines recommend patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Background The COVID-19 pandemic is responsible for many hospitalizations in intensive
care units (ICU), with widespread use of invasive mechanical ventilation (IMV) which …

The primary objective of this multicenter, observational, retrospective study was to assess
the incidence rate of ventilator-associated pneumonia (VAP) in coronavirus disease 2019 …

Background During the intensive care units'(ICUs) reorganization that was forced by the
COVID-19 emergency, attention to traditional infection control measures may have been …

Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …

Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …